Total Funding
59
62
Total FundingGrant raised
Growth Score
-5 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
160472
VITRUVIAE develops biotherapeutics targeting sugar and lipid signatures on viruses and cancers to treat drug resistance.
- Sonia Sequeira: Founder and Chief Executive Officer
About the Company
VITRUVIAE is an early-stage biotechnology company focused on developing innovative pan-drug solutions to treat cancer and virus drug resistance. The company’s lead biotherapeutic, VTRU200, targets aberrant sugar and lipid signatures on viruses and cancers. VITRUVIAE employs a unique approach by targeting specific signatures not present in normal
cells, encoded by mRNA, to aid medical professionals in treatment. The company aims to restore quality of life through its revolutionary biotherapeutic solutions.
